Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Cells|November 8, 2024
High-Dose Chemotherapy and Autologous or Allogeneic Transplantation in Aggressive B-Cell Lymphoma-Is There Still a Role?Michael Daunov, Koen van BesienAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 30, 2025
Pegylated Interferons: Still a Major Player for the Treatment of Myeloproliferative NeoplasmsMichael Daunov, Rebecca B KlisovicAmerican Journal of Perinatology|January 29, 2024
A Description of IVIG Use in Term Neonates with ABO IncompatibilityMichael Daunov, Andrea Schlosser, Sindhoosha Malay, et al.Nature Communications|August 27, 2024
The TGFβ type I receptor kinase inhibitor vactosertib in combination with pomalidomide in relapsed/refractory multiple myeloma: a phase 1b trialEhsan Malek, Priyanka S Rana, Muthulekha Swamydas, et al.Research Square|July 28, 2023
Vactosertib, a novel TGF-β1 type I receptor kinase inhibitor, improves T-cell fitness: a single-arm, phase 1b trial in relapsed/refractory multiple myelomaEhsan Malek, Priyanka S Rana, Muthulekha Swamydas, et al.Journal of the National Comprehensive Cancer Network : JNCCN|May 8, 2023
Are NCI Cancer Centers Providing Adolescents and Young Adults With Cancer Focused Clinical Services? A National SurveyKatherine Daunov, Michael Daunov, Kara Noskoff, et al.Blood|May 19, 2026
Consensus Recommendations for CAR T-Cell Administration in Adult Acute Lymphoblastic Leukemia: a Modified Delphi StudyLori Muffly, Noelle V Frey, Gregory W Roloff, et al.Blood|February 5, 2026
Blinatumomab Nonresponse Correlates with Poor Survival After BrexucabtageneHrishikesh Krishna Srinagesh, Vishal K Gupta, Amy Zhang, et al.Pageof 1